%0 Journal Article
%T Autosomal Dominant Pseudohypoaldosteronism Type 1 in an Infant with Salt Wasting Crisis Associated with Urinary Tract Infection and Obstructive Uropathy
%A Sasigarn A. Bowden
%A Corin Cozzi
%A Scott E. Hickey
%A Devon Lamb Thrush
%A Caroline Astbury
%A Sushma Nuthakki
%J Case Reports in Endocrinology
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/524647
%X Type 1 pseudohypoaldosteronism (PHA1) is a salt wasting syndrome caused by renal resistance to aldosterone. Primary renal PHA1 or autosomal dominant PHA1 is caused by mutations in mineralocorticoids receptor gene (NR3C2), while secondary PHA1 is frequently associated with urinary tract infection (UTI) and/or urinary tract malformations (UTM). We report a 14-day-old male infant presenting with severe hyperkalemia, hyponatremic dehydration, metabolic acidosis, and markedly elevated serum aldosterone level, initially thought to have secondary PHA1 due to the associated UTI and posterior urethral valves. His serum aldosterone remained elevated at 5 months of age, despite resolution of salt wasting symptoms. Chromosomal microarray analysis revealed a deletion of exons 3¨C5 in NR3C2 in the patient and his asymptomatic mother who also had elevated serum aldosterone level, confirming that he had primary or autosomal dominant PHA1. Our case raises the possibility that some patients with secondary PHA1 attributed to UTI and/or UTM may instead have primary autosomal dominant PHA1, for which genetic testing should be considered to identify the cause, determine future recurrence risk, and possibly prevent the life-threatening salt wasting in a subsequent family member. Future clinical research is needed to investigate the potential overlapping between secondary PHA1 and primary autosomal dominant PHA1. 1. Introduction Pseudohypoaldosteronism (PHA) is a disorder caused by aldosterone resistance with subsequent impaired sodium reabsorption and potassium excretion. The broad category of PHA includes PHA type 1 (PHA1) and PHA type 2 (PHA2, also known as GordonĄ¯s syndrome or familial hyperkalemic hypertension). PHA1 is subdivided into primary (genetic) and secondary (or transient) forms. Primary PHA1 has two clinically and genetically distinct forms [1]: (1) the autosomal dominant or sporadic form (also called renal form), caused by mutations in the mineralocorticoid receptor (MR) coding gene NR3C2 [2] and (2) the autosomal recessive or generalized PHA1, which is caused by mutations in genes encoding subunits of the epithelial sodium channel [3]. The secondary (transient) PHA1 has been described in infants suffering from urinary tract malformations or urinary tract infections (UTI) or both [4¨C12]. We present the first case report of autosomal dominant PHA1 with an intragenic deletion of NR3C2, presenting with salt wasting crisis associated with UTI and posterior urethral valves, thereby mimicking secondary PHA1. 2. Case Presentation The male patient, the second child of
%U http://www.hindawi.com/journals/crie/2013/524647/